MAPT and early-onset autosomal dominant Alzheimer disease: It has been argued that consequence of either tau pathology or mitral cell degeneration that leads to a dramatic loss of smell in Alzheimer’s disease might be a useful screening tool (Wesson et al., 2011; Attems et al., 2014).